129 In the index

Hexarelin HEX

A strong growth-hormone-boosting peptide, closely related to a compound also sold under the name examorelin, studied in small human trials for hormone release and possibly heart protection. It clearly raises growth hormone, but repeated use makes the body less responsive to it over time.

Also known as Examorelin, examorelina, examoreline, 09QF37C617, examorelinum, RefChem:139696, His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2

Effects Build muscle Heal

Routes Subcutaneous

Legal status Research chemical

WADA Banned at all times

Molecular Structure of C₄₇H₅₈N₁₂O₆

Drag to rotate · scroll to zoom

PubChem has no 3D conformer for this molecule, so this is the flat structure.

Chemistry

Formula: C47H58N12O6
Molar mass: 887.0
CAS: 140703-51-1
PubChem CID: 6918297
IUPAC name: (2S)-6-amino-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-(2-methyl-1H-indol-3-yl)propanoyl]amino]propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamide
InChIKey: RVWNMGKSNGWLOL-GIIHNPQRSA-N

Reported dosing

User-reported

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 100-200 mcg per dose

Reported range 100-300 mcg per dose

Route Subcutaneous injection

Frequency 1-3 times daily

Duration 6-8 week course (unregulated use), often cycled due to rapid desensitization

Not FDA-approved; sold only as a research chemical. Known to desensitize its own growth-hormone-releasing effect faster than other GHRPs with continued use.

Where this comes from Small published clinical studies; user-reported/research-chemical vendor literature

There is no approved human dosing for this compound. The figures above are what users and vendors report, not what has been established as safe or effective. Treat them as a record of what is done, not as guidance.